Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049451

EVP & Chief Strategy Officer sold 9,464 shares at an average $14.88 ($140,802)

  • EVP & Chief Strategy Officer acquired 4,145 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Soffer Gad EVP & Chief Strategy Officer 2017-08-15 Sale −7,000 $15.00 $105,000 257,409 D
Soffer Gad EVP & Chief Strategy Officer 2017-08-15 Option exercise +4,145 261,554 D
Soffer Gad EVP & Chief Strategy Officer 2017-08-16 Sale −2,464 $14.53 $35,802 259,090 D
Derivatives
Soffer Gad EVP & Chief Strategy Officer 2017-08-15 Option exercise · Restricted Stock Units −4,145 6,910 D
Open-market sales · 9,464 sh · avg $14.88 · $140,802
Loading xslF345X03/doc4.xml…